Literature DB >> 26928202

Epidemiologic and laboratory surveillance of the measles outbreak in the Federation of Bosnia and Herzegovina, February 2014-April 2015.

I Salimović-Bešić1, M Šeremet2, J M Hübschen3, M Hukić4, N Tihić5, S Ahmetagić6, Z Delibegović5, A Pilav7, M Mulaomerović8, J Ravlija8, C P Muller3, A Dedeić-Ljubović2.   

Abstract

A measles outbreak with two epidemic waves involving 4649 probable and laboratory-confirmed cases was recorded in six out of ten cantons of the Federation of Bosnia and Herzegovina between February 2014 and April 2015. The majority of the patients had never received measles vaccination (3115/4649, 67.00%), and the vaccination status of another 23% was unknown (1066/4649). A total of 281 blood samples were tested serologically. Virus detection was performed using 44 nasopharyngeal swabs. About 57% (161/281) of the laboratory-investigated sera were immunoglobulin M positive, and 95% (42/44) of the swabs were reverse transcriptase-PCR positive. Phylogenetic analysis of sequences obtained from 30 swab samples showed circulation of two variants of genotype D8, but no genotype D4 strains as detected in 2007. Similar involvement of all age groups indicates a problem with vaccine refusal resulting from antivaccination activities in addition to gaps in immunization coverage during the war and postwar period (1992-1998). Differences in ethnicity, vaccine coverage, compliance with review policies of vaccination records and potentially also travel habits may partially explain why only six of ten cantons were affected by the outbreak. The second epidemic wave may in part be due to large-scale migrations due to catastrophic floods in 2014. As a result of the epidemic, 6- to 12-month-old children may now be vaccinated against measles during outbreaks, and public health recommendations for interventions have been strengthened. Additional efforts are required to implement the measures throughout the cantons.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bosnia and Herzegovina; measles; measles–mumps–rubella (MMR) vaccine; outbreaks; vaccine-preventable diseases; vaccines and immunization

Mesh:

Substances:

Year:  2016        PMID: 26928202     DOI: 10.1016/j.cmi.2016.02.005

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  Challenges to Achieving Measles Elimination, Georgia, 2013-2018.

Authors:  Nino Khetsuriani; Ketevan Sanadze; Rusudan Chlikadze; Nazibrola Chitadze; Tamar Dolakidze; Tamta Komakhidze; Lia Jabidze; Shahin Huseynov; Myriam Ben Mamou; Claude Muller; Khatuna Zakhashvili; Judith M Hübschen
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

Review 2.  Infectious Diseases Associated with Hydrometeorological Hazards in Europe: Disaster Risk Reduction in the Context of the Climate Crisis and the Ongoing COVID-19 Pandemic.

Authors:  Maria Mavrouli; Spyridon Mavroulis; Efthymios Lekkas; Athanassios Tsakris
Journal:  Int J Environ Res Public Health       Date:  2022-08-17       Impact factor: 4.614

3.  Large measles outbreak introduced by asylum seekers and spread among the insufficiently vaccinated resident population, Berlin, October 2014 to August 2015.

Authors:  Dirk Werber; Alexandra Hoffmann; Sabine Santibanez; Annette Mankertz; Daniel Sagebiel
Journal:  Euro Surveill       Date:  2017-08-24

4.  Epidemiological, clinical and laboratory characteristics of the measles resurgence in the Republic of Serbia in 2014-2015.

Authors:  Snežana Medić; Vladimir Petrović; Goranka Lončarević; Milena Kanazir; Ivana Begović Lazarević; Slavica Rakić Adrović; Maja Bančević; Claude P Muller; Judith M Hübschen
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.